COMPANY

MELIAPHARM INC

MELIAPHARM INC: marketing authorisation holder for Desmopressin, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

DesmopressinDESMOPRESSIN (DIN 02346788), Cancelled Post Market Regulator Health Canada
DesmopressinDESMOPRESSIN (DIN 02346796), Cancelled Post Market Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.